Aydin, P. Et Al. 2023. The melatonin agonist ramelteon attenuates bleomycin-induced lung fibrosis by suppressing the NLRP3/TGF-Β1/HMGB1 signaling pathway. Advances in Medical Sciences , vol.68, no.2 , 322-331.

Aydin, P., Aksakalli-Magden, Z. B., Civelek, M. S., Karabulut-Uzuncakmak, S., Mokhtare, B., ÖZKARACA, M., ... ALPER, F.(2023). The melatonin agonist ramelteon attenuates bleomycin-induced lung fibrosis by suppressing the NLRP3/TGF-Β1/HMGB1 signaling pathway. Advances in Medical Sciences , vol.68, no.2, 322-331.

Aydin, Pelin Et Al. "The melatonin agonist ramelteon attenuates bleomycin-induced lung fibrosis by suppressing the NLRP3/TGF-Β1/HMGB1 signaling pathway," Advances in Medical Sciences , vol.68, no.2, 322-331, 2023

Aydin, Pelin Et Al. "The melatonin agonist ramelteon attenuates bleomycin-induced lung fibrosis by suppressing the NLRP3/TGF-Β1/HMGB1 signaling pathway." Advances in Medical Sciences , vol.68, no.2, pp.322-331, 2023

Aydin, P. Et Al. (2023) . "The melatonin agonist ramelteon attenuates bleomycin-induced lung fibrosis by suppressing the NLRP3/TGF-Β1/HMGB1 signaling pathway." Advances in Medical Sciences , vol.68, no.2, pp.322-331.

@article{article, author={Pelin Aydin Et Al. }, title={The melatonin agonist ramelteon attenuates bleomycin-induced lung fibrosis by suppressing the NLRP3/TGF-Β1/HMGB1 signaling pathway}, journal={Advances in Medical Sciences}, year=2023, pages={322-331} }